Logo for Zymeworks Inc

Zymeworks Investor Relations Material

Latest events

Logo for Zymeworks Inc

Q4 2023

Zymeworks
Logo for Zymeworks

Q4 2023

6 Mar, 2024
Logo for Zymeworks

Corporate Presentation

15 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Zymeworks Inc

Access all reports
Zymeworks Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation bispecific, multifunctional biotherapeutics, initially focused on the treatment of cancer. The company's proprietary Azymetric platform combines its modular and flexible Fc engineering with non-Fc-containing domains designed to enable modulation of therapeutic index in order to address multiple biological targets simultaneously from a single protein. The partnering team brings together a comprehensive set of skills and expertise spanning early drug discovery through product commercialization.